The Partnership to Amend 42 CFR Part 2, a coalition of nearly 50 health care organizations including the AHA, applauded Congress’ important step to modernize privacy regulations affecting the disclosure of patients’ substance use disorder treatment records.

The Coronavirus Aid, Relief, and Economic Security Act (CARES) Act, which President Trump signed into law last week, includes the reintroduced, AHA-supported Protecting Jessica Grubb’s Legacy Act.

By more closely aligning 42 CFR Part 2 with HIPAA regulations, “the new law will improve the ability of hospitals and health systems to receive and share vital information necessary to provide safer, better coordinated care to patients with substance use disorder,” said AHA Executive Vice President Tom Nickels. “We applaud Congress for taking this important step, which will save lives and promote high-quality care."

Related News Articles

Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…
Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…